Bone Density, Muscle Weakness
Conditions
Keywords
Pilot Study, Bone Density, Vibration Therapy, Vitamin D, Muscle Strength
Brief summary
This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity. Study Objectives: • Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.
Interventions
DEVICEDynatronics VF5 Model vibration platform
The Dynatronics VF5 Model vibration platform is a specialized therapeutic device designed for rehabilitation and wellness applications. Utilizing advanced vibration technology, it provides whole-body vibration therapy that can enhance muscle strength, improve flexibility, and promote overall physical well-being. The platform features adjustable frequency and amplitude settings, allowing customization based on individual needs. Its user-friendly interface and robust, durable design make it suitable for both clinical and mobile therapy settings. Additionally, the compact and portable nature of the VF5 facilitates easy storage and transport, while safety features such as non-slip surfaces ensure user protection.
DEVICEPlacebo Dynatronics VF5 Model vibration platform
Placebo intensity with vertical vibration of 0.2 mm
Sponsors
Jouf University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
The participants will be unaware of whether they are receiving vibration therapy, and the individual performing the assessment will be different from the one administering the treatment
Eligibility
Sex/Gender
MALE
Age
50 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Male participants aged 50 years or older * Participants with physical activity or exercise program involvement * Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year. * Participants must be non-smokers and not receiving hormone or calcium supplement therapy
Exclusion criteria
* Participants unable to stand on the WBV platform * Participants with conditions contraindicating vibration therapy * Participants participating in other clinical trials
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bone Density | 8 weeks | Changes in BMD (measured by DXA scanner), |
| Grip Strength | 8 weeks | hand grip strength (measured by a hand-held dynamometer) |
| Vitamin D | 8 weeks | Vitamin D levels (measured by high-performance liquid chromatography). |
Countries
Saudi Arabia
Contacts
Primary ContactFahad Alanazi, PhD
Outcome results
None listed